dermatan sulfate has been researched along with Inflammatory Response Syndrome, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagiwara, S; Hidaka, S; Hishiyama, S; Iwasaka, H; Noguchi, T | 1 |
| Kleinschmidt, S; Seyfert, UT | 1 |
1 trial(s) available for dermatan sulfate and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Heparin-associated thrombocytopenia (HAT)--still a diagnostic and therapeutical problem in clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arterial Occlusive Diseases; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Female; Gangrene; Heparin; Heparitin Sulfate; Humans; Middle Aged; Phenprocoumon; Platelet Activation; Platelet Aggregation; Platelet Count; Pulmonary Embolism; Recurrence; Systemic Inflammatory Response Syndrome; Thrombocytopenia; Thromboembolism; Thrombophlebitis | 1995 |
1 other study(ies) available for dermatan sulfate and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats.
Topics: Animals; Chondroitin Sulfates; Dermatan Sulfate; Endotoxins; Heparitin Sulfate; HMGB1 Protein; I-kappa B Proteins; Interleukin-10; Interleukin-6; Male; Mice; NF-kappa B; Rats; Rats, Wistar; Respiratory Distress Syndrome; Survival Rate; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 2008 |